ESRRA and neoplasm: Encouragingly, regarding the prediction of EC occurrence, the PPARγ/ERRα ratio is superior not only to PPARγ or ERRα alone but also to currently used clinical serum tumor markers, namely, CA125, CA199, CA153, AFP and CEA.